← Evidence map

ReviewActa pharmaceutica Sinica. B2020

Targeting human MutT homolog 1 (MTH1) for cancer eradication: current progress and perspectives.

Yizhen Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33354500